| Myeloid cell lines | |
| KG1a (myeloblastic, CD34+) | ++ |
| TF-1 (erythroid progenitor, CD34+) | + |
| U937 (promonocytic) | ++ |
| KU.812 (megakaryoblastic) | − |
| K562 (erythroleukemic) | ++ |
| Lymphoid cell lines | |
| BOB (B-lymphoid) | − |
| COX (B-lymphoid) | − |
| U266 (plasmocytoma) | ++ |
| NCI-H929 (plasmocytoma) | ++ |
| BV173 (pre-B-leukemic) | − |
| Myeloid cell lines | |
| KG1a (myeloblastic, CD34+) | ++ |
| TF-1 (erythroid progenitor, CD34+) | + |
| U937 (promonocytic) | ++ |
| KU.812 (megakaryoblastic) | − |
| K562 (erythroleukemic) | ++ |
| Lymphoid cell lines | |
| BOB (B-lymphoid) | − |
| COX (B-lymphoid) | − |
| U266 (plasmocytoma) | ++ |
| NCI-H929 (plasmocytoma) | ++ |
| BV173 (pre-B-leukemic) | − |
++ indicates strong binding (> 500 cells/mm2); +, intermediate binding (100-500 cells/mm2); −, no binding above background.